The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
- PMID: 14651756
- PMCID: PMC305372
- DOI: 10.1186/1472-6890-3-5
The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
Abstract
BACKGROUND: The purpose of the present correlative immunohistochemical study was to assess the utility of cytokeratin (CK7 and CK20) expression in the diagnosis of short-segment Barrett esophagus, particularly its efficacy in differentiating Barrett mucosa from intestinal metaplasia of the gastric cardia and corpus. METHODS: Two groups of endoscopic biopsy specimens were examined, including 20 endoscopic biopsy specimens of short-segment Barrett esophagus (Group A) and equal number exhibiting Helicobacter pylori associated intestinal metaplasia of the gastric cardia and corpus (Group B). All were investigated by immunohistochemistry using the standard ABC method for CK7 and CK20 expression. Fisher's exact test was used for statistical analysis of Barrett CK7/20 and gastric CK7/20 patterns between the groups. RESULTS: The anticipated pattern of reactivity in Barrett mucosa (CK7: strong diffuse positivity in superficial and deep glands; CK20: positivity in surface epithelium and superficial glands) was seen in 2 cases of Group A specimens. The expected gastric pattern (CK7: patchy immunostaining with variable involvement of deep glands; CK20: patchy immunostaining of superficial and deep glands in incomplete intestinal metaplasia / absence of CK7 immunoreactivity with strong CK20 staining in superficial and deep glands in complete intestinal metaplasia) was seen in 8 cases of Group B specimens. The respective sensitivity and false-negativity values of CK7/20 staining for Barrett pattern in Group A were 10% and 90%, respectively. These values for gastric pattern in Group B were 40% and 60%, respectively. The specificity and false-positivity values of both patterns were same (100% and 0%, respectively). There was no statistically significant difference for Barrett pattern between the two groups (P = 0.487), while the observation of gastric pattern was significantly higher in Group B than in Group A (P = 0.02). CONCLUSIONS: We concluded that these hypothesized and recently applied diagnostic criteria involving CK7 and CK20 immunoreactivity are not reliable in distinguishing short-segment Barrett esophagus from intestinal metaplasia as seen in gastric cardia and corpus.
Figures




Similar articles
-
Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.Cancer. 2002 Feb 1;94(3):820-31. doi: 10.1002/cncr.10215. Cancer. 2002. PMID: 11857318
-
Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.Histol Histopathol. 2002 Apr;17(2):445-54. doi: 10.14670/HH-17.445. Histol Histopathol. 2002. PMID: 11962749
-
Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.Hum Pathol. 1999 Mar;30(3):288-94. doi: 10.1016/s0046-8177(99)90007-2. Hum Pathol. 1999. PMID: 10088547
-
What is the role of cytokeratins in Barrett/cardia differentiation?Arch Pathol Lab Med. 2005 Feb;129(2):181-2. doi: 10.5858/2005-129-181-WITROC. Arch Pathol Lab Med. 2005. PMID: 15679416 Review.
-
Adenocarcinoma of the upper esophagus arising in heterotopic gastric mucosa: common pathogenesis with Barrett's adenocarcinoma?Virchows Arch. 2002 Oct;441(4):406-11. doi: 10.1007/s00428-002-0697-7. Virchows Arch. 2002. PMID: 12516606 Review.
Cited by
-
Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia.J Clin Pathol. 2005 Jul;58(7):722-4. doi: 10.1136/jcp.2004.024265. J Clin Pathol. 2005. PMID: 15976339 Free PMC article.
-
The use of cytokeratin stain to distinguish Barrett's esophagus from contiguous tissues: a systematic review.Dig Dis Sci. 2007 May;52(5):1345-54. doi: 10.1007/s10620-006-9399-3. Epub 2007 Mar 21. Dig Dis Sci. 2007. PMID: 17373588
-
Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.World J Gastroenterol. 2005 Oct 28;11(40):6360-5. doi: 10.3748/wjg.v11.i40.6360. World J Gastroenterol. 2005. PMID: 16419166 Free PMC article.
-
Short histological kaleidoscope - recent findings in histology. Part IV.Rom J Morphol Embryol. 2024 Jul-Sep;65(3):377-393. doi: 10.47162/RJME.65.3.01. Rom J Morphol Embryol. 2024. PMID: 39529332 Free PMC article. Review.
References
-
- Haggitt RC. Adenocarcinoma in Barrett's esophagus: a new epidemic? Hum Pathol. 1992;23:475–476. - PubMed
-
- Winters C, Jr, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF, 3rd, Johnson DA, Cruess DF, Cotelingam JD, Gurney MS, et al. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987;92:118–124. - PubMed
-
- Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 1994;25:982–983. - PubMed
-
- Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med. 1976;295:476–480. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials